ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional Results available

PhII ICb With/Without Erbitux in MBC Pts

ClinicalTrials.gov ID: NCT00248287

Public ClinicalTrials.gov record NCT00248287. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Phase II Study of Weekly Irinotecan/Carboplatin (ICb) With or Without Cetuximab (Erbitux) in Patients With Metastatic Breast Cancer

Study identification

NCT ID
NCT00248287
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
US Oncology Research
Industry
Enrollment
154 participants

Conditions and interventions

Interventions

  • Irinotecan + Carboplatin Drug
  • irinotecan + Carboplatin + erbitux Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 27, 2005
Primary completion
Nov 30, 2025
Completion
Nov 30, 2026
Last update posted
Jan 28, 2025

2005 – 2026

United States locations

U.S. sites
59
U.S. states
22
U.S. cities
56
Facility City State ZIP Site status
Birmingham Hematology and Oncology Birmingham Alabama 35205
Hematology Oncology Asscociates Phoenix Arizona 85012
Northern AZ Hematology & Oncology Assoc Sedona Arizona 86336
Rocky Mountain Cancer Center-Rose Denver Colorado 80220
Northwestern Connecticut Oncology Hematology Associates Torrington Connecticut 06790
Melbourne Internal Medicine Associates Melbourne Florida 32901
Florida Cancer Institute New Port Richey Florida 34655
Ocala Oncology Center Ocala Florida 34474
Cancer Centers of Florida, P.A. Ocoee Florida 34761
Hematology Oncology Associates of IL Chicago Illinois 60611
Central Indiana Cancer Center Indianapolis Indiana 46227
Kansas City Cancer-Southwest Overland Park Kansas 66210
Maryland Oncology Hematology, P.A. Columbia Maryland 21044
Minnesota Oncology Hematology, P.A. Minneapolis Minnesota 55404
Missouri Cancer Associates Columbia Missouri 65201
Arch Medical Services, Inc St Louis Missouri 63141
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89109
NH Oncology-Hematology PA Hooksett New Hampshire 03106
Hematology-Oncology Associates of NNJ, P.A. Morristown New Jersey 07960
Summit Medical Group Summit New Jersey 07901
New York Oncology Hematology, P.C. Albany New York 12208
New York Oncology Hematology, PC Rexford New York 12148
Interlakes Oncology Hematology, PC Rochester New York 14623
Raleigh Hematology Oncology Clinic Cary North Carolina 27511
Greater Dayton Cancer Center Kettering Ohio 45409
Willamette Valley Cancer Center Eugene Oregon 97401
Cancer Center of the Carolinas, Seneca Seneca South Carolina 29672
Texas Cancer Center-Abilene(South) Abilene Texas 79606
Texas Cancer Center Arlington Texas 76014
Texas Oncology Cancer Center Austin Texas 78731
Mamie McFaddin Ward Cancer Center Beaumont Texas 77702
Texas Oncology, P.A. - Bedford Bedford Texas 76022
Texas Cancer Center at Medical City Dallas Texas 75230
Texas Oncology, P.A. Dallas Texas 75231
The Texas Cancer Center Dallas Texas 75237
Texas Oncology, P.A. Dallas Texas 75246
Texas Oncology Center - Denton Denton Texas 76210
El Paso Cancer Treatment Ctr El Paso Texas 79915
Texas Oncology, P.A. Fort Worth Texas 76104
San Antonio Tumor & Blood Clinic Fredericksburg Texas 78624
Texas Oncology, P.A. Houston Texas 77024
Longview Cancer Center Longview Texas 75601
South Texas Cancer Center-McAllen McAllen Texas 78503
Texas Cancer Center of Mesquite Mesquite Texas 75150
Allison Cancer Center Midland Texas 79701
HOAST - New Braunfels New Braunfels Texas 78131
West Texas Cancer Center Odessa Texas 79761
Paris Regional Cancer Center Paris Texas 75460
Texas Cancer Center-Sherman Sherman Texas 75090
Texas Oncology Cancer Center-Sugar Land Sugar Land Texas 77479
Tyler Cancer Center Tyler Texas 75702
Waco Cancer Care and Research Center Waco Texas 76712
Virginia Oncology Associates Norfolk Virginia 23505
Onc and Hem Associates of SW VA, Inc. Salem Virginia 24153
Puget Sound Cancer Center-Emonds Edmonds Washington 98026
Puget Sound Cancer Center-Seattle Seattle Washington 98133
Cancer Care Northwest-South Spokane Washington 99202
Northwest Cancer Specialists-Vancouver Vancouver Washington 98684
Yakima Valley Mem Hosp/North Star Lodge Yakima Washington 98902

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00248287, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2025 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00248287 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →